Renal Shared Care Arrangements

These Shared Care Arrangements are for DMARDs prescribed to RENAL TRANSPLANT PATIENTS ONLY.  Some content and recommendations may differ from the SCA’s for patients receiving these drugs for conditions other than renal transplant. This is due to the specialist service clinical recommendations and monitoring for managing renal transplant patients.

To preserve vital venous access, blood monitoring for RENAL TRANSPLANT PATIENTS will be done by the renal specialist service, unless otherwise notified or the patient develops an intercurrent illness which would require bloods to be taken by primary care.

For RENAL TRANSPLANT PATIENTS the renal specialist service will review results, for monitoring they have undertaken. All results should also be reviewed by Primary Care routinely prior to prescribing, and if addition monitoring due to an intercurrent illness.

Listed below are the locally agreed Renal Transplant Shared Care Arrangements:

• Azathioprine Renal Transplant
• Ciclosporin Renal Transplant
• Mycophenolate Mofetil Renal Transplant
• Tacrolimus Renal Transplant